Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIM Transplantation for IBS
NCT02857257Phase 2Unknown
- Sponsor
- Uppsala University
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of anaerobically cultivated human intestinal microbiota in irritable bowel syndrome (IBS), sponsored by Uppsala University. Status: unknown.
02
Drugs
anaerobically cultivated human intestinal microbiota
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02857257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857257.